Streetbeat News

Analyst Ratings

ATRC

AtriCure (NASDAQ:ATRC) has received diverse analyst ratings over the last three months, with a shift towards more bullish perspectives. The average 12-month price target for ATRC has increased to $49.75, up 6.99% from $46.50. Analyst actions include ratings and price target adjustments by Needham and JMP Securities, reflecting evolving market conditions and AtriCure's performance. AtriCure specializes in surgical treatments for atrial fibrillation and other conditions, showing strong financial health with significant revenue growth and efficient cost management despite a lower market capitalization compared to peers.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 12:00 pm

DKNG

Needham analyst Bernie McTernan reiterated a Buy rating on DraftKings (NASDAQ:DKNG) and maintained a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:59 am

PENN

Needham analyst Bernie McTernan maintains a Buy rating on PENN Entertainment (NASDAQ:PENN) but lowers the price target from $33 to $32.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:57 am

BHVN

RBC Capital analyst Leonid Timashev has initiated coverage on Biohaven (NYSE:BHVN) with an Outperform rating and set a price target of $62. This new coverage could influence investor sentiment and potentially impact Biohaven's stock price in the short term.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:56 am

NVDA

Loop Capital analyst Ananda Baruah has initiated coverage on NVIDIA (NASDAQ:NVDA) with a Buy rating and set a price target of $1200.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:50 am

CALC

JonesTrading analyst Catherine Novack initiates coverage on CalciMedica (NASDAQ:CALC) with a Buy rating and a price target of $22.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:46 am

LBPH

Citigroup analyst David Hoang initiates coverage on Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy rating and a price target of $40.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:44 am

ARM

Daiwa Capital analyst Louis Miscioscia downgraded ARM Holdings (NASDAQ:ARM) from Buy to Neutral but raised the price target from $63 to $130.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:42 am

NKE

Oppenheimer analyst Brian Nagel downgraded Nike (NKE) from Outperform to Perform and set a price target of $110.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:40 am

DBX

JMP Securities analyst Patrick Walravens downgraded Dropbox (NASDAQ:DBX) from Market Outperform to Market Perform, indicating a neutral outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:34 am